Growth Metrics

Fulgent Genetics (FLGT) Notes Payables (2021 - 2026)

Fulgent Genetics' Notes Payables history spans 6 years, with the latest figure at $482000.0 for Q1 2026.

  • On a quarterly basis, Notes Payables rose 1.26% to $482000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was $482000.0, a 1.26% increase, with the full-year FY2025 number at $476000.0, up 15.53% from a year prior.
  • Notes Payables hit $482000.0 in Q1 2026 for Fulgent Genetics, up from $476000.0 in the prior quarter.
  • Over the last five years, Notes Payables for FLGT hit a ceiling of $6.1 million in Q1 2022 and a floor of $412000.0 in Q2 2024.
  • Historically, Notes Payables has averaged $2.4 million across 5 years, with a median of $482000.0 in 2026.
  • Biggest five-year swings in Notes Payables: plummeted 92.64% in 2024 and later rose 15.53% in 2025.
  • Tracing FLGT's Notes Payables over 5 years: stood at $5.6 million in 2022, then plummeted by 79.02% to $1.2 million in 2023, then crashed by 65.17% to $412000.0 in 2024, then increased by 15.53% to $476000.0 in 2025, then rose by 1.26% to $482000.0 in 2026.
  • Business Quant data shows Notes Payables for FLGT at $482000.0 in Q1 2026, $476000.0 in Q4 2025, and $476000.0 in Q3 2025.